Aβ deposition and hyperphosphorylated p-Tau protein are key pathological changes in AD, and intervention with Eri and Hom reduced the amount of amyloid and p-Tau in the brains of mice injected with Aβ25–35 (Figure 3). The gene discussed is MAPT; the disease is Alzheimer disease.